GleamWall
中文EN

MDT Medtronic plc

Electromedical & Electrotherapeutic Apparatus · NYSE · SEC CIK 1613103 · Fiscal year ends 04/24

Financial factors as of 2026-07-31 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.8%
TTM net income YoY12.3%
TTM EPS YoY12.2%
Revenue 3-yr CAGR6.0%
Net income 3-yr CAGR13.1%

Margins

Gross margin65.0%
Operating margin18.1%
Net margin13.9%
FCF margin16.3%
EBITDA margin23.5%

Returns

ROE10.7%
ROA5.7%
ROIC (approx.)7.1%
Asset turnover0.41x

Leverage & solvency

Liabilities / assets45.5%
Debt / equity0.56x
Current ratio2.07x
Interest coverage9.37x

Cash quality & payout

Operating cash flow / net income1.54x
Accruals ratio-3.0%
Payout ratio69.8%
Capex / revenue5.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q12026-07-312026Q4*2026-04-242026Q32026-01-232026Q22025-10-242026Q12025-07-252025Q4*2025-04-252025Q32025-01-242025Q22024-10-25
Income statement
Revenue$9.76B$9.81B$9.02B$8.96B$8.58B$8.93B$8.29B$8.40B
Cost of revenue$3.42B$3.40B$3.26B$3.06B$3.00B$3.15B$2.78B$2.95B
Gross profit$6.34B$6.41B$5.76B$5.90B$5.58B$5.78B$5.51B$5.46B
R&D expense$771.00M$671.00M$722.00M$754.00M$726.00M$684.00M$675.00M$697.00M
SG&A expense$3.20B$3.06B$2.96B$2.96B$2.81B$2.72B$2.72B$2.76B
Operating income$1.76B$1.87B$1.46B$1.69B$1.45B$1.44B$1.65B$1.59B
Interest expense$186.00M$176.00M$181.00M$181.00M$176.00M$174.00M$179.00M$209.00M
Pretax income$1.77B$1.83B$1.40B$1.60B$1.30B$1.26B$1.54B$1.56B
Income tax$289.00M$575.00M$254.00M$215.00M$255.00M$199.00M$237.00M$281.00M
Net income$1.47B$1.24B$1.14B$1.37B$1.04B$1.06B$1.29B$1.27B
EBITDA$2.49B$2.59B$1.77B$1.97B$2.19B$2.28B$1.91B$1.86B
EPS (basic)1.15—0.891.070.81—1.010.99
EPS (diluted)1.14—0.891.070.81—1.010.99
Dividends declared per share0.720.710.710.710.710.700.700.70
Weighted avg. shares (diluted)1.29B—1.29B1.29B1.29B—1.29B1.29B
Banking
Net interest income$102.00M$89.00M$85.00M$89.00M$120.00M$147.00M$114.00M$137.00M
Balance sheet
Cash & equivalents$1.69B$1.95B$1.15B$1.28B$1.27B$2.22B$1.24B$1.39B
Short-term investments$7.13B$7.27B$7.24B$7.04B$6.85B$6.75B$6.68B$6.59B
Receivables$6.36B$6.64B$6.36B$6.39B$6.26B$6.51B$6.12B$6.26B
Inventory$6.21B$5.95B$6.31B$6.16B$5.89B$5.48B$5.61B$5.48B
Current assets$24.39B$24.79B$24.07B$24.00B$23.22B$23.81B$22.51B$22.44B
PP&E, net$7.47B$7.42B$7.18B$7.16B$7.01B$6.84B$6.59B$6.44B
Goodwill$43.19B$42.59B$41.89B$41.81B$42.01B$41.74B$40.82B$41.16B
Intangibles$10.24B$10.15B$10.34B$10.77B$11.22B$11.67B$12.18B$12.42B
Total assets$93.31B$93.03B$91.48B$91.35B$90.97B$91.68B$89.97B$90.04B
Current liabilities$11.80B$11.66B$9.49B$9.94B$11.53B$12.88B$11.84B$12.20B
Short-term debt$2.54B$1.79B$191.00M$1.42B$2.43B$2.87B$2.62B$3.72B
Long-term debt$25.62B$26.17B$27.88B$27.68B$26.18B$25.64B$23.98B$24.61B
Total debt$28.15B$27.96B$28.07B$29.10B$28.61B$28.52B$26.61B$28.33B
Total liabilities$42.46B$42.96B$42.29B$42.49B$42.84B$43.42B$40.36B$41.33B
Shareholders' equity$50.23B$49.46B$48.98B$48.65B$47.89B$48.02B$49.39B$48.49B
Net debt$26.46B$26.01B$26.92B$27.82B$27.34B$26.30B$25.37B$26.93B
Shares outstanding1.28B1.28B1.28B1.28B1.28B1.28B1.28B1.28B
Cash flow statement
Operating cash flow$1.79B$2.57B$2.74B$925.00M$1.09B$2.53B$2.57B$958.00M
Capital expenditure$503.00M$488.00M$444.00M$468.00M$504.00M$459.00M$476.00M$404.00M
Free cash flow$1.29B$2.08B$2.30B$457.00M$584.00M$2.07B$2.10B$554.00M
Investing cash flow-$1.62B-$917.00M-$816.00M-$482.00M-$719.00M-$490.00M-$843.00M-$345.00M
Financing cash flow-$343.00M-$888.00M-$2.09B-$395.00M-$1.38B-$1.34B-$1.75B-$534.00M
Depreciation & amortization$729.00M$716.00M$308.00M$282.00M$748.00M$840.00M$268.00M$262.00M
Stock-based compensation$125.00M$95.00M$95.00M$182.00M$86.00M$89.00M$98.00M$159.00M
Dividends paid$921.00M$908.00M$911.00M$910.00M$910.00M$897.00M$897.00M$897.00M
Share buybacks$267.00M$435.00M$105.00M$372.00M$123.00M$274.00M$181.00M$288.00M

Free plan shows the latest 8 periods; Pro shows all 53 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.